Julie Sroga Rios

Julie Sroga Rios

Auto-generated profile, based on publicly available information

Julie Sroga Rios

University of Cincinnati College of Medicine, Cincinnati, Ohio

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SAShannel R Adams
Shannel R Adams
SMSo Maezawa
So Maezawa
KAKris G Alavattam
Kris G Alavattam
HAHironori Abe
Hironori Abe
ASAkihiko Sakashita
Akihiko Sakashita
SNSatoshi H. Namekawa
Satoshi H. Namekawa
The sex chromosomes are enriched with germline genes that are activated during the late stages of spermatogenesis. Due to meiotic sex chromosome inactivation (MSCI), these sex chromosome-linked genes must escape silencing for activation in spermatids, thereby ensuring their functions for male reproduction. RNF8, a DNA damage response protein, and SCML2, a germline-specific Polycomb protein, are two major, known regulators of this process. Here, we show that RNF8 and SCML2 cooperate to regulate ubiquitination during meiosis, an early step to establish active histone modifications for subsequent gene activation. Double mutants of Rnf8 and Scml2 revealed that RNF8-dependent monoubiquitination of histone H2A at Lysine 119 (H2AK119ub) is deubiquitinated by SCML2, demonstrating interplay between RNF8 and SCML2 in ubiquitin regulation. Additionally, we identify distinct functions of RNF8 and SCML2 in the regulation of ubiquitination: SCML2 deubiquitinates RNF8-independent H2AK119ub but does not deubiquitinate RNF8-dependent polyubiquitination. RNF8-dependent polyubiquitination is required for the establishment of H3K27 acetylation, a marker of active enhancers, while persistent H2AK119ub inhibits establishment of H3K27 acetylation. Following the deposition of H3K27 acetylation, H3K4 dimethylation is established as an active mark on poised promoters. Together, we propose a model whereby regulation of ubiquitin leads to the organization of poised enhancers and promoters during meiosis, which induce subsequent gene activation from the otherwise silent sex chromosomes in postmeiotic spermatids. To produce unimpaired sperm, precise activation of germline-specific genes is an essential step during the late stages of spermatogenesis. However, sex chromosomes carrying these genes become silenced in a chromosome-wide manner during meiosis in a process called meiotic sex chromosome inactivation. Sex chromosome inactivation is maintained from meiosis into postmeiotic spermatids. Thus, to ensure the function of sex chromosome-linked (sex-linked) genes required for male reproduction, these genes must escape silencing for activation in spermatids. Here, we unravel the epigenetic mechanisms that underlie the activation of sex-linked genes from otherwise inactive sex chromosomes in the male germline. We determine the mechanism by which two factors regulate gene activation: one is RNF8, a DNA damage response protein, and the other is SCML2, a germline-specific Polycomb protein. Our data suggest that, during meiosis, RNF8 and SCML2 cooperate to regulate ubiquitination, which establishes active epigenetic modifications on enhancers and promoters for subsequent gene activation; these memories are maintained through meiotic divisions to induce gene activation in spermatids. Importantly, this study uncovers novel epigenetic mechanisms that underlie specific gene activation in spermatids and illuminates potential causes of male infertility.

5 October 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JRJulie S Rios
Julie S Rios
EGEleni A Greenwood
Eleni A Greenwood
MPMaryEllen Pavone
MaryEllen Pavone
MCMarcelle Ivonne Cedars
Marcelle Ivonne Cedars
RLRichard S Legro
Richard S Legro
HHHeather G Huddleston
Heather G Huddleston
Context The relationship between reproductive and cardiometabolic aging is unclear. It is unknown if the relationship differs across different clinical populations. Objective To determine whether markers of ovarian reserve are associated with cardiometabolic risk in reproductive aged women with unexplained infertility (UI), polycystic ovary syndrome (PCOS), and regularly cycling women (OVA). Design and setting Cross-sectional data from 8 US-based academic centers. Participants Women aged 25–40 from 3 clinical populations: 870 with UI, 640 with PCOS, and 921 community-based OVA. Main Outcome Measures Multivariable linear regression models were used to relate anti-mullerian hormone (AMH) and antral follicle count with cardiometabolic parameters including body mass index (BMI), waist circumference (WC), fasting glucose and insulin, homeostasis model assessment-insulin resistance (HOMA-IR), lipids, and C-reactive protein. Results In age and study site-adjusted models, AMH inversely related to BMI in the UI and OVA groups (P = 0.02 and P < 0.001). Among women with PCOS, AMH inversely related to BMI (P < 0.001), and also to WC (P < 0.001), fasting insulin (P < 0.01), HOMA-IR (P < 0.01), triglycerides (P = 0.04), and C-reactive protein (P < 0.001) and directly related to higher total (P = 0.02), low-density lipoprotein (P < 0.01), and high-density lipoprotein cholesterol (P < 0.01). In OVA, AMH also varied inversely with WC (P < 0.001), fasting insulin (P = 0.02), and HOMA-IR (P = 0.02). Adjustment for BMI eliminated associations in the OVA group but in PCOS, the relationship of AMH to total (P = 0.03) and low-density lipoprotein cholesterol (P = 0.003) remained. Conclusion Associations observed between AMH and cardiometabolic indices are largely explained by BMI in women with and without PCOS. (J Clin Endocrinol Metab XX: 0-0, 2019)

19 June 2021 in F&S Reports
Verified
Journal Article
Open access
JRJulie S. Rios
Julie S. Rios
RCR. Matthew Coward
R. Matthew Coward
KHKarl R. Hansen
Karl R. Hansen
KBKurt T. Barnhart
Kurt T. Barnhart
MCMarcelle I. Cedars
Marcelle I. Cedars
ASAnne Z. Steiner
Anne Z. Steiner
To examine the factors associated with increased deoxyribonucleic acid fragmentation index (DFI), evaluate the pregnancy outcomes of men with increased DFI, and compare three independent DFI assays. Secondary analysis. Nine US-based fertility centers. Infertile men (N = 147) with sperm concentration ≤15 × 106/mL, motility ≤40%, or normal morphology ≤4% were enrolled. The female partners were ovulatory, ≤40 years old, and had documented tubal patency. At a baseline visit, the men provided a semen sample. The couples attempted conception without assistance for 3 months and with ovarian stimulation and intrauterine insemination in the subsequent 3 months. The DFI was analyzed using the sperm chromatin structure assay (SCSA) with increased DFI defined as >30%. The predictors of increased DFI were determined by a multivariable linear regression model. The pregnancy outcomes were compared using the χ2 test. The independent DFI assays (SCSA, deoxynucleotidyl transferase-mediated dUTP nick end labeling, and Comet) were compared with Pearson and Spearman correlations. The 19% of men with increased DFI were older (36.0 vs. 33.0 years) and had lower total sperm motility (38.2% ± 20.5% vs. 45.2% ± 15.6%). Increased male age was found to be a significant predictor of DFI (0.75, 95% confidence interval [0.06, 1.45]). Increased DFI was not associated with conception or live birth. There was a modest correlation of the deoxynucleotidyl transferase-mediated dUTP nick end labeling assay with the SCSA (r = 0.34) and Comet assay (r = 0.19). Older age was associated with increased DFI among infertile men. The DFI assays were only weakly correlated, indicating a standard definition of DFI is needed to truly interrogate how sperm deoxyribonucleic acid fragmentation impacts male fertility.